312 related articles for article (PubMed ID: 31515764)
21. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
Bosch DE; Yeh MM
Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
[TBL] [Abstract][Full Text] [Related]
22. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
Saich R; Chapman R
World J Gastroenterol; 2008 Jan; 14(3):331-7. PubMed ID: 18200656
[TBL] [Abstract][Full Text] [Related]
23. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.
Emek E; Serin A; Sahin T; Yazici P; Yuzer Y; Tokat Y; Bozkurt B
Transplant Proc; 2019 Sep; 51(7):2439-2441. PubMed ID: 31405746
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis.
Zhang Y; Gao X; He Z; Jia H; Chen M; Wang X; Hong L; Cui Y; Wan J
Liver Int; 2022 Aug; 42(8):1814-1822. PubMed ID: 35689520
[TBL] [Abstract][Full Text] [Related]
25. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease.
Yanai H; Matalon S; Rosenblatt A; Awadie H; Berdichevski T; Snir Y; Kopylov U; Katz L; Stein A; Mlynarsky L; Tulchinsky H; Konikoff FM; Horin SB; Braun M; Ben-Ari Z; Chowers Y; Baruch Y; Shibolet O; Dotan I
J Crohns Colitis; 2015 Feb; 9(2):177-84. PubMed ID: 25518055
[TBL] [Abstract][Full Text] [Related]
27. Impact of ulcerative colitis on liver-related outcomes of children with primary sclerosing cholangitis.
Sathiaseelan M; Bolia R; Barallon R; Alex G; Hardikar W; Rajanayagam J
J Paediatr Child Health; 2022 Jul; 58(7):1221-1227. PubMed ID: 35373867
[TBL] [Abstract][Full Text] [Related]
28. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
[TBL] [Abstract][Full Text] [Related]
29. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
[TBL] [Abstract][Full Text] [Related]
30. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India.
Singh A; Midha V; Narang V; Kedia S; Mahajan R; Dhoble P; Kahlon BK; Dhaliwal AS; Tripathi A; Kalra S; Jain NP; Bansal N; Banerjee R; Desai D; Dutta U; Ahuja V; Sood A
Intest Res; 2023 Oct; 21(4):452-459. PubMed ID: 36453008
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
[TBL] [Abstract][Full Text] [Related]
32. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Lynch KD; Chapman RW; Keshav S; Montano-Loza AJ; Mason AL; Kremer AE; Vetter M; de Krijger M; Ponsioen CY; Trivedi P; Hirschfield G; Schramm C; Liu CH; Bowlus CL; Estes DJ; Pratt D; Hedin C; Bergquist A; de Vries AC; van der Woude CJ; Yu L; Assis DN; Boyer J; Ytting H; Hallibasic E; Trauner M; Marschall HU; Daretti LM; Marzioni M; Yimam KK; Perin N; Floreani A; Beretta-Piccoli BT; Rogers JK; ; Levy C
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):179-187.e6. PubMed ID: 31100458
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.
Park YE; Cheon JH; Park JJ; Kim YJ; Choi CH; Park Y; Park SJ; Kim TI; Kim WH
Int J Colorectal Dis; 2018 Oct; 33(10):1497-1500. PubMed ID: 29987360
[TBL] [Abstract][Full Text] [Related]
34. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.
Kaplan GG; Laupland KB; Butzner D; Urbanski SJ; Lee SS
Am J Gastroenterol; 2007 May; 102(5):1042-9. PubMed ID: 17313496
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
Mínguez Sabater A; Conde Amiel I; Ladrón Abia P; Martínez Delgado S; Camarasa Pérez Á; Berenguer M
Gastroenterol Hepatol; 2022 Mar; 45(3):177-185. PubMed ID: 34052401
[TBL] [Abstract][Full Text] [Related]
36. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
[TBL] [Abstract][Full Text] [Related]
37. Primary sclerosing cholangitis: an experience from India.
Kochhar R; Goenka MK; Das K; Nagi B; Bhasin DK; Chawla YK; Vaiphei K; Singh K; Dilawari JB
J Gastroenterol Hepatol; 1996 May; 11(5):429-33. PubMed ID: 8743914
[TBL] [Abstract][Full Text] [Related]
38. Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy.
Treeprasertsuk S; Björnsson E; Sinakos E; Weeding E; Lindor KD
World J Gastrointest Pharmacol Ther; 2013 Aug; 4(3):61-8. PubMed ID: 23919218
[TBL] [Abstract][Full Text] [Related]
39. [Clinicobiological and morphological profiles of primary sclerosing cholangitis in Tunisia].
Héla K; Asma OK; Ali A; Nadia BM; Mohamed MA; Nabil T; Abdeljabbar G; Béchir Z; Nabyl BM
Tunis Med; 2014 May; 92(5):323-8. PubMed ID: 25504385
[TBL] [Abstract][Full Text] [Related]
40. Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis.
Ataseven H; Parlak E; Yüksel I; Başar O; Ertuğrul I; Saşmaz N; Sahin B
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):312-5. PubMed ID: 19502174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
